News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
696,181 Results
Type
Article (39566)
Company Profile (247)
Press Release (656368)
Section
Business (204137)
Career Advice (2007)
Deals (35419)
Drug Delivery (94)
Drug Development (81023)
Employer Resources (172)
FDA (16157)
Job Trends (14849)
News (345099)
Policy (32504)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2548)
Accelerated approval (2)
Adcomms (20)
Allergies (80)
Alliances (49381)
ALS (83)
Alzheimer's disease (1349)
Antibody-drug conjugate (ADC) (109)
Approvals (16158)
Artificial intelligence (228)
Autoimmune disease (14)
Automation (14)
Bankruptcy (360)
Best Places to Work (11641)
BIOSECURE Act (18)
Biosimilars (101)
Biotechnology (175)
Bladder cancer (58)
Brain cancer (24)
Breast cancer (246)
Cancer (1991)
Cardiovascular disease (160)
Career advice (1673)
Career pathing (29)
CAR-T (139)
Cell therapy (395)
Cervical cancer (18)
Clinical research (65711)
Collaboration (763)
Compensation (449)
Complete response letters (19)
COVID-19 (2581)
CRISPR (35)
C-suite (210)
Cystic fibrosis (98)
Data (1951)
Decentralized trials (2)
Denatured (16)
Depression (38)
Diabetes (248)
Diagnostics (6330)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (111)
Drug pricing (95)
Drug shortages (25)
Duchenne muscular dystrophy (85)
Earnings (86202)
Editorial (31)
Employer branding (21)
Employer resources (146)
Events (111654)
Executive appointments (638)
FDA (17257)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (686)
Gene editing (96)
Generative AI (18)
Gene therapy (276)
GLP-1 (684)
Government (4378)
Grass and pollen (4)
Guidances (48)
Healthcare (18808)
Huntington's disease (22)
IgA nephropathy (22)
Immunology and inflammation (103)
Indications (26)
Infectious disease (2711)
Inflammatory bowel disease (131)
Inflation Reduction Act (8)
Influenza (46)
Intellectual property (86)
Interviews (311)
IPO (16486)
IRA (40)
Job creations (3629)
Job search strategy (1422)
Kidney cancer (9)
Labor market (34)
Layoffs (452)
Leadership (15)
Legal (7899)
Liver cancer (70)
Lung cancer (291)
Lymphoma (133)
Machine learning (4)
Management (58)
Manufacturing (265)
MASH (60)
Medical device (13320)
Medtech (13325)
Mergers & acquisitions (19401)
Metabolic disorders (629)
Multiple sclerosis (69)
NASH (16)
Neurodegenerative disease (76)
Neuropsychiatric disorders (24)
Neuroscience (1821)
NextGen: Class of 2025 (6518)
Non-profit (4476)
Northern California (2417)
Now hiring (37)
Obesity (339)
Opinion (201)
Ovarian cancer (73)
Pain (77)
Pancreatic cancer (76)
Parkinson's disease (132)
Partnered (20)
Patents (203)
Patient recruitment (93)
Peanut (46)
People (57087)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20469)
Phase II (28936)
Phase III (21565)
Pipeline (1024)
Podcasts (44)
Policy (110)
Postmarket research (2563)
Preclinical (8656)
Press Release (64)
Prostate cancer (93)
Psychedelics (30)
Radiopharmaceuticals (244)
Rare diseases (355)
Real estate (5903)
Recruiting (65)
Regulatory (22140)
Reports (46)
Research institute (2318)
Resumes & cover letters (349)
Rett syndrome (3)
RNA editing (4)
RSV (39)
Schizophrenia (64)
Series A (120)
Series B (78)
Service/supplier (11)
Sickle cell disease (50)
Southern California (2094)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3572)
State (2)
Stomach cancer (13)
Supply chain (59)
The Weekly (25)
United States (21086)
Vaccines (656)
Venture capitalists (37)
Webinars (12)
Weight loss (224)
Women's health (33)
Worklife (15)
Date
Today (229)
Last 7 days (737)
Last 30 days (2741)
Last 365 days (33644)
2025 (7964)
2024 (35223)
2023 (40085)
2022 (51180)
2021 (55720)
2020 (54090)
2019 (46551)
2018 (35022)
2017 (32114)
2016 (31484)
2015 (37558)
2014 (31328)
2013 (26349)
2012 (28574)
2011 (29270)
2010 (27333)
Location
Africa (718)
Alabama (49)
Alaska (7)
Arizona (223)
Arkansas (13)
Asia (37716)
Australia (6165)
California (5511)
Canada (1866)
China (474)
Colorado (245)
Connecticut (256)
Delaware (126)
Europe (80865)
Florida (818)
Georgia (192)
Idaho (57)
Illinois (495)
India (23)
Indiana (290)
Iowa (9)
Japan (142)
Kansas (100)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (826)
Massachusetts (4144)
Michigan (209)
Minnesota (369)
Mississippi (2)
Missouri (75)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (62)
New Jersey (1571)
New Mexico (28)
New York (1582)
North Carolina (916)
North Dakota (7)
Northern California (2417)
Ohio (190)
Oklahoma (14)
Oregon (33)
Pennsylvania (1253)
Puerto Rico (9)
Rhode Island (26)
South America (1095)
South Carolina (18)
South Dakota (1)
Southern California (2094)
Tennessee (92)
Texas (821)
Utah (164)
Virginia (128)
Washington D.C. (57)
Washington State (512)
West Virginia (3)
Wisconsin (49)
696,181 Results for "avid bioservices inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Avid Bioservices, Inc. Provides Notice of Fundamental Change and Make-Whole Fundamental Change to Holders of its Convertible Notes in Connection with Completed Merger
February 6, 2025
·
6 min read
Press Releases
Avid Bioservices Launches New Company Website Designed to Boost Company Brand Awareness and Enhance the Visitor Experience
February 10, 2025
·
2 min read
Press Releases
Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners
February 6, 2025
·
5 min read
Biotech Beach
Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance
Avid Bioservices, Inc. announced that the company has achieved a Committed Badge from EcoVadis, one of the world’s most trusted providers of business sustainability ratings.
May 23, 2024
·
2 min read
Press Releases
Avid Bioservices Files Investor Presentation Highlighting Value Maximizing Transaction with GHO and Ampersand
January 9, 2025
·
9 min read
Biotech Beach
Avid Bioservices to Participate at Upcoming May 2024 Investor Conferences
Avid Bioservices, Inc., a dedicated biologics contract development and manufacturing organization working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, announced that the company will participate at two upcoming investor conferences.
May 7, 2024
·
1 min read
Press Releases
Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2024
December 10, 2024
·
9 min read
Press Releases
Avid Bioservices Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by GHO and Ampersand
December 30, 2024
·
7 min read
Press Releases
Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024
Avid Bioservices, Inc. today announced that it will report financial results for the quarter and fiscal year ended April 30, 2024, on July 2, 2024, after market close and will host a webcast at 1:30 PM Pacific Time (4:30 PM Eastern Time).
July 1, 2024
·
1 min read
Biotech Beach
Avid Bioservices Announces Pricing of Private Placement of Convertible Notes
Avid Bioservices, Inc., a dedicated biologics contract development and manufacturing organization, announced the pricing of $160 million aggregate principal amount of 7.00% Convertible Senior Notes due 2029.
March 7, 2024
·
5 min read
1 of 69,619
Next
